{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:33:42Z","timestamp":1790476422586,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Ischemic stroke currently lacks evidence-based neuroprotective agents, primarily due to the challenge of timely intervention, which often occurs after the onset of irreversible neuronal damage. To address this, this study investigates the PARthanatos pathway, a form of regulated cell death triggered by DNA damage. Utilizing MNNG-induced cellular PARthanatos models, we screened a library of 2,939 traditional Chinese medicine monomers and identified Bruceine E, a natural product derived from Brucea javanica (bitterwood), as a potent inhibitor of PARthanatos at nanomolar concentrations, acting via the inhibition of PARP-1 overactivation. Bruceine E effectively prevents the accumulation of PAR-modified proteins, mitigates mitochondrial membrane potential collapse, and inhibits AIF nuclear translocation. Mechanistically, molecular docking, molecular dynamics simulations, surface plasmon resonance (SPR), and thermal stability assays demonstrate that Bruceine E interacts with the NAD + catalytic pocket of PARP-1 through six hydrogen bonds, exhibiting fast-binding and slow-dissociation kinetics. Furthermore, PARP1 overexpression rescue experiments confirmed that PARP1 overexpression markedly reversed the neuroprotective effect of Bruceine E, indicating that its pharmacological action is specifically dependent on PARP1 regulation. In a permanent distal middle cerebral artery occlusion (pdMCAO) model of C57BL\/6 mice, a single intraperitoneal injection of 10\u00a0mg\/kg Bruceine E administered 4.5\u00a0h after occlusion reduced infarct volume by approximately 80.2%, histological evidence confirmed that a single intraperitoneal administration of BE provided effective neuroprotection against ischemic brain injury.<\/jats:p>","DOI":"10.3389\/fphar.2026.1843673","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:39:46Z","timestamp":1782106786000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Bruceine E, a natural quassinoid from Brucea javanica, inhibits PARthanatos via targeting PARP1 in ischemic stroke"],"prefix":"10.3389","volume":"17","author":[{"given":"Chang","family":"Wei","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Wannan Medical University","place":["Wuhu, China"]},{"name":"Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases,Wannan Medical University","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-ze","family":"Zhai","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Wannan Medical University","place":["Wuhu, China"]},{"name":"Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases,Wannan Medical University","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-ling","family":"Yue","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Wannan Medical University","place":["Wuhu, China"]},{"name":"Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases,Wannan Medical University","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-zhe","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Wannan Medical University","place":["Wuhu, China"]},{"name":"Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases,Wannan Medical University","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Cao","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Wannan Medical University","place":["Wuhu, China"]},{"name":"Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases,Wannan Medical University","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-wen","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Wannan Medical University","place":["Wuhu, China"]},{"name":"Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases,Wannan Medical University","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-huan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Changzheng Hospital, Naval Medical University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hui","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Wannan Medical University","place":["Wuhu, China"]},{"name":"Anhui Province Key Laboratory of Basic Research and Transformation of Age-related Diseases,Wannan Medical University","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12906-017-1610-x","article-title":"Antidiabetic effects of Brucea javanica seeds in type 2 diabetic rats","volume":"17","author":"Ablat","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1542431","DOI":"10.3389\/fphar.2025.1542431","article-title":"Diffusion constraints in neuroprotection: implications for clinical trials","volume":"16","author":"Aksenov","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3390\/ijms18091989","article-title":"Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS\/NF-\u03baB and HO-1\/Nrf2 pathways","volume":"18","author":"Bahar","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6165192","DOI":"10.1155\/2018\/6165192","article-title":"Silibinin induced human glioblastoma cell apoptosis concomitant with autophagy through simultaneous inhibition of mTOR and YAP","volume":"2018","author":"Bai","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet, Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1317620","DOI":"10.3389\/fphar.2023.1317620","article-title":"A review of brucea javanica: metabolites, pharmacology and clinical application","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100329","DOI":"10.1016\/j.labinv.2024.100329","article-title":"Nuclear nicotinamide adenine dinucleotide deficiency by Nmnat1 deletion impaired hepatic insulin signaling, mitochondrial function, and hepatokine expression in mice fed a high-fat diet","volume":"104","author":"Dong","year":"2024","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/01.str.30.10.2038","article-title":"Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke","volume":"30","author":"Dyker","year":"1999","journal-title":"Stroke"},{"key":"B9","doi-asserted-by":"publisher","first-page":"156178","DOI":"10.1016\/j.prp.2025.156178","article-title":"Parthanatos: a redox-dependent cell death pathway in cardiovascular disease and myocardial aging","volume":"274","author":"Fang","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/bph.12201","article-title":"Identification through high-throughput screening of 4\u2019-methoxyflavone and 3\u2019,4\u2019-dimethoxyflavone as novel neuroprotective inhibitors of parthanatos","volume":"169","author":"Fatokun","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/17474930241308142","article-title":"World stroke organization: global stroke fact sheet 2025","volume":"20","author":"Feigin","year":"2025","journal-title":"Int. J. Stroke Off. J. Int. Stroke Soc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet (lond. Engl.)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"102454","DOI":"10.1016\/j.bbrep.2026.102454","article-title":"Bifendate inhibits cell PARthanatos by activating the MEK\/ERK pathway","volume":"45","author":"Hu","year":"2026","journal-title":"Biochem. Biophys. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7292","DOI":"10.3390\/ijms23137292","article-title":"Molecular mechanisms of parthanatos and its role in diverse diseases","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"662034","DOI":"10.3389\/fneur.2021.662034","article-title":"Targeting parthanatos in ischemic stroke","volume":"12","author":"Koehler","year":"2021","journal-title":"Front. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/biom14111398","article-title":"Resveratrol inhibits nucleosome binding and catalytic activity of PARP1","volume":"14","author":"Koshkina","year":"2024","journal-title":"Biomolecules"},{"key":"B18","doi-asserted-by":"publisher","first-page":"103406","DOI":"10.1016\/j.redox.2024.103406","article-title":"Isoliquiritigenin alleviates cerebral ischemia-reperfusion injury by reducing oxidative stress and ameliorating mitochondrial dysfunction via activating the Nrf2 pathway","volume":"77","author":"Lan","year":"2024","journal-title":"Redox Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"B20","doi-asserted-by":"publisher","first-page":"102758","DOI":"10.1016\/j.eclinm.2024.102758","article-title":"Global, regional, and national burden of ischemic stroke, 1990-2021: an analysis of data from the global burden of disease study 2021","volume":"75","author":"Li","year":"2024","journal-title":"Eclinicalmedicine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1158\/1078-0432.CCR-14-0084","article-title":"ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy","volume":"20","author":"Lin","year":"2014","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/jnc.15464","article-title":"Emerging role of PARP-1 and PARthanatos in ischemic stroke","volume":"160","author":"Liu","year":"2022","journal-title":"J. Neurochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/ana.78041","article-title":"Back again to the future: a new era for cerebroprotection","volume":"99","author":"Lyden","year":"2026","journal-title":"Ann. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/jpp\/rgaf016","article-title":"Bruceine E attenuates hepatic steatosis through modulation of PI3K\/AKT\/NF\u03baB signalling pathway","volume":"77","author":"Man","year":"2025","journal-title":"J. Pharm. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1091\/mbc.E18-10-0650","article-title":"NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival","volume":"30","author":"Murata","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s43587-024-00627-x","article-title":"Converting cell death into senescence by PARP1 inhibition improves recovery from acute oxidative injury","volume":"4","author":"Nehme","year":"2024","journal-title":"Nat. Aging"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/STROKEAHA.122.040073","article-title":"Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030","volume":"54","author":"Pu","year":"2023","journal-title":"Stroke"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1611055","DOI":"10.3389\/fcell.2025.1611055","article-title":"Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology","volume":"13","author":"Qi","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"108058","DOI":"10.1016\/j.phrs.2025.108058","article-title":"Poly (ADP-ribose) polymerase (PARP) inhibitors approved for the treatment of cancer","volume":"222","author":"Roskoski","year":"2025","journal-title":"Pharmacol. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/01.STR.0000196957.55928.ab","article-title":"Time is brain--quantified","volume":"37","author":"Saver","year":"2006","journal-title":"Stroke"},{"key":"B31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"aad6872","DOI":"10.1126\/science.aad6872","article-title":"A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1","volume":"354","author":"Wang","year":"2016","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/svn-2021-001374","article-title":"China stroke statistics: an update on the 2019 report from the national center for healthcare quality management in neurological diseases, China national clinical research center for neurological diseases, the Chinese stroke association, national center for chronic and non-communicable disease control and prevention, Chinese center for disease control and prevention and institute for global neuroscience and stroke collaborations","volume":"7","author":"Wang","year":"2022","journal-title":"Stroke Vasc. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1097\/CM9.0000000000003725","article-title":"Analysis and prediction of disease burden of stroke and its subtypes in China from 1990 to 2040","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J. (Engl.)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.3390\/molecules27186105","article-title":"Comprehensive bioinformatics analysis combined with wet-lab experiments to find target proteins of Chinese medicine monomer","volume":"27","author":"Xu","year":"2022","journal-title":"Molecules"},{"key":"B36","doi-asserted-by":"publisher","first-page":"116174","DOI":"10.1016\/j.bcp.2024.116174","article-title":"Parthanatos: mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke","volume":"228","author":"Yang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"116724","DOI":"10.1016\/j.biopha.2024.116724","article-title":"Role of pattern recognition receptors in the development of MASLD and potential therapeutic applications","volume":"175","author":"Yu","year":"2024","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1487436","DOI":"10.3389\/fphar.2025.1487436","article-title":"Medroxyprogesterone promotes neuronal survival after cerebral ischemic stroke by inhibiting PARthanatos","volume":"16","author":"Yue","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"156912","DOI":"10.1016\/j.phymed.2025.156912","article-title":"Brusatol induced ferroptosis in osteosarcoma cells by modulating the Keap1\/Nrf2\/SLC7A11 signaling pathway","volume":"144","author":"Zhang","year":"2025","journal-title":"Phytomed, Int. J. Phytother. Phytopharm."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1843673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T05:39:47Z","timestamp":1782106787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1843673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":39,"alternative-id":["10.3389\/fphar.2026.1843673"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1843673","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"article-number":"1843673"}}